title: The changing scene of the regulation of medicines in the UK. Paper from The Use of Medicines: Regulation & Clinical Pharmacology in the 21st Century Symposium - December 2003.
abstract: The Medicines and Healthcare products Regulatory Agency was established in April 2003 by the merger of the Medicines Control Agency (MCA) and the Medical Devices Agency (MDA). This paper describes the scientific and organizational basis for the merger and describes the various challenges facing this new Agency.
authors.affiliation: Medicines and Healthcare products Regulatory Agency (MHRA), Market Towers 1 Nine Elms Lane, London SW8 5NQ, UK. alasdair.breckenridge@mhra.gsi.gov.uk
authors.forename: Alasdair
authors.initials: A
authors.lastname: Breckenridge
mesh_terms: D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006801:Humans; D007880:Legislation, Drug / Q000639:trends; D010601:Pharmacology, Clinical / Q000331:legislation & jurisprudence* / Q000639:trends; D006113:United Kingdom